Melatonin and cell death: Differential actions on apoptosis in normal and cancer cells

Cellular and Molecular Life Sciences

Volumn 60, Issue 7, 2003, Pages 1407-1426

  Sainz, R M ^a   Mayo, J C ^a   Rodriguez, C ^b   Tan, D X ^a   Lopez Burillo, S ^a   Reiter, R J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Apoptosis; Cancer cells; Free radicals; Immune system; Melatonin; Neuroprotection

Indexed keywords

CASPASE 9; FREE RADICAL; MELATONIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; CANCER CELL; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROTECTION; CHROMATIN CONDENSATION; EMBRYO DEVELOPMENT; ENZYME SPECIFICITY; IMMUNE SYSTEM; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN FAMILY; REVIEW;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL DEATH; HUMANS; MELATONIN; MODELS, BIOLOGICAL; NEOPLASMS; NEURONS; REFERENCE VALUES;

ANIMALIA;

EID: 0042869981     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-2319-1     Document Type: Review

References (199)

1. Hengartner M. O. (2000) The biochemistry of apoptosis. Nature 407: 770-776
2. Kerr J. F., Wyllie A. H. and Currie A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257
3. Wyllie A. H., Kerr J. F. and Currie A. R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306
4. Thornberry N. A. and Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1326
5. Gupta S. (2001) Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci. 69: 2957-2964
6. Earnshaw W. C., Martins L. M. and Kaufmann S. H. (1999) Mammalian caspases: structure, activation, substrates and function during apoptosis. Annu. Rev. Biochem 68: 383-424
7. Baud V. and Karin M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell. Biol. 11: 372-377
8. Marsters S. A., Pitti R. M., Donahue C. J., Ruppert S., Bauer K. D. and Ashkenazi A. (1996) Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr. Biol. 6: 750-752
9. Srivasta S. K. (2001) TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 3: 535-546
10. Hsu H., Shu H. B., Pan M. G. and Goeddel D. V. (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308
11. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281: 1309-1312
12. Garcia-Ruiz C., Colell A., Marim M., Morales A. and Fernandez-Checa J. C. (1997) Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 272: 11369-11377
13. Bossy-Wetzel E., Newmeyer D. D. and Green D. R. (1998) Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17: 37-49
14. Zamzami N. and Kroemer G. (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat. Rev. Mol. Cell. Biol. 2: 67-71
15. Kroemer G. and Reed J. C. (2000) Mitochondrial control of cell death. Nat. Med. 6: 513-519
16. Allen R. T., Cluck M. W and Agrawal D. K. (1998) Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell. Mol. Life Sci. 54: 427-445
17. Tatton W. G. and Olanow C. W. (1999) Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim Biophys. Acta 1410: 195-213
18. Saikumar P., Dong Z., Mikhailov V., Denton M., Weinberg J. M. and Venkatachalam M. A. (1999) Apoptosis: definition, mechanisms, and relevance to disease. Am. J. Med. 107: 489-506
19. Makin G. and Dive C. (2001) Apoptosis and cancer chemotherapy. Trends Cell. Biol. 11: S22-S25
20. Raha S. and Robinson B. H. (2001) Mitochondria, oxygen free radicals and apoptosis. Am. J. Med. Gen. 106: 62-70
21. Fridovich I. (1995) Superoxide radical and superoxide dismutases. Ann. Rev. Biochem. 64: 97-112
22. Du G., Mouithys-Mickalad A., Sluse-Goffart C. M., DroyLefaix M. T. and Sluse F. E. (1998) Generation of superoxide anion by mitochondria and impairment of their function during anoxia and reoxygenetion in vitro. Free Radic. Biol. Med. 25: 1066-1074
23. rd edn, Oxford University Press, New York
24. Forrest V. J., Kang Y. H., McClain D. E., Robinson D. H. and Ramakrishnan N. (1994) Oxidative stress-induced apoptosis prevented by Trolox. Free Radic. Biol. Med. 16: 675-684
25. Warters R. L. (1992) Radiation-induced apoptosis in a murine T-cell hybridoma. Cancer Res 52: 883-890
26. Buttke T. M. and Sandstrom P. A. (1994) Oxidative stress as a mediator of apoptosis. Immunol. Today 15: 7-10
27. Cadenas E. and Davies K. J. (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29: 222-230
28. Chandra J., Samali A. and Orrenius S. (2000) Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med 29: 323-333
29. Parke D. V. and Sapota A. (1996) Chemical toxicity and reactive oxygen species. Int. J. Occup. Med. Environ. Health. 9: 331-340
30. Nathan C. and Xie Q. W. (1994) Nitric oxide synthases: roles, tolls and controls. Cell 78: 915-918
31. Tan S., Sagara Y., Liu Y., Maher P. and Schubert D. (1998) The regulation of reactive oxygen species production during programmed cell death. J. Cell. Biol. 141: 1423-1432
32. van der Dobbelsteen D. J., Nobel C. S. I., Schlegel J., Cotgreave I. A., Orrenius S. and Slater A. F. (1996) Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J. Biol. Chem. 271: 15420-15427
33. Voehringer D. W., McConkey D. J., McDonell T. J., Brisvay S. and Meyn R. E. (1998) Bcl-2 expression causes redistribution of glutathine to the nucleus. Proc. Natl. Acad. Sci. USA 95: 2956-2960
34. Hall A. G. (1999) The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest. 29: 238-245
35. Hampton M. B. and Orrenius S. (1997) Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 414: 552-556
36. Nathan C. and Xie Q. W. (1994) Nitric oxide synthases: roles, tolls and controls. Cell 78: 915-918
37. Bosca L. and Hortelano S. (1999) Mechanisms of nitric oxide-dependent apoptosis: involvement of mitochondrial mediators. Cell. Signal. 11: 239-244
38. Zhang D., Okada S., Yu Y., Zheng P., Yamaguchi R. and Kasai H. (1997) Vitamin E inhibits apoptosis, DNA modification and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res. 57: 2410-2414
39. Maellaro E., Bello B. D. and Comporti M. (1996) Protection by ascorbate against apoptosis of thymocytes: implications of ascorbate-induced nonlethal oxidative stress and poly(ADP-ribosyl)ation. Exp. Cell. Res. 226: 105-113
40. Offen D., Ziv I., Sternin H., Melamed E. and Hochman A. (1996) Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp. Neurol. 141: 32-39
41. Pappolla M. A.,. Sos M., Omar R. A., Bick R. J., Hickson-Bick D. L., Reiter R. J. et al. (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17: 1683-1690
42. Maccarrone M., Lorenzon T., Guerrieri P. and Agro A. F. (1999) Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265: 27-34
43. Ferrari G., Yan C. Y. and Greene L. A. (1995) N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15: 2857-2866
44. Cossarizza A., Franceschi C., Monti D., Salvioli S., Bellesia E., Rivabene R. et al. (1995) Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell. Res. 220: 232-240
45. Mayer M. and Noble M (1994) N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc. Natl. Acad. Sci. USA 91: 7496-7500
46. Sainz R. M., Mayo J. C., Uria H., Kotler M., Antolin I., Rodriguez C. et al. (1995) The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res. 19: 178-188
47. Reiter R. J. (1991) Melatonin: the chemical expression of darkness. Mol. Cell. Endocrinol. 79: C153-C158
48. Reiter R. J. (1991) Pineal melatonin: cell biology of its synthesis and its physiological interaction. Endocr. Rev. 12: 151-180
49. Van Tassel D. L., Roberts N., Lewy A. and O'Neill S. D. (2001) Melatonin in plant organs. J. Pineal Res. 31: 8-15
50. Reiter R. J., Tan D. X., Burkhardt S. and Manchester L. C. (2001). Melatonin in plants. Nutr. Rev. 59: 286-290
51. Hardeland R. (1999) Melatonin and 5-methoxytryptamine in non-metazoans. Reprod. Nutr. Dev. 39: 399-408
52. Reiter R. J. (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12: 151-180
53. Reiter R. J. (1980) The pineal and its hormones in the control of reproduction in mammals. Endocr. Rev. 1: 109-131
54. Dubocovich M. L. (1983) Melatonin is a potent modulator of dopamine release in the retina. Nature 306: 782-784
55. Mahle C. D., Goggins G. D., Agarwal P., Ryan E. and Watson A. J. (1997) Melatonin modulates vascular smooth muscle tone. J. Biol. Rhythms 12: 690-696
56. Guerrero J. M. and Reiter R. J. (2002) Melatonin-immune system relationships. Curr. Topics Med. Chem. 2: 167-180
57. Bartsch H., Bartsch C., Simon W. E., Flehmig B., Ebels I. and Lippert T. H. (1992) Antitumor activity of the pineal gland: effect of unidentified substances versus the effect of melatonin. Oncology 49: 27-30
58. Blask D. E., Sauer L. A., Dauchy R. T., Holowachuk E. W., Ruhoff M. S. and Kopff H. S., (1999) Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res. 59: 4693-4701
59. Blask D. E., Sauer L. A. and Dauchy R. T. (2002) Melatonin as a chronobiotic/anticancer agent; cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Topics Med. Chem. 2: 113-132
60. Hill S. and Blask D. E. (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48: 6121-6126
61. Cos S., Fernandez R., Guezmes A. and Sanchez-Barcelo E. J. (1998) Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 58: 4383-4390
62. Cos S., Mediavilla M. D., Fernandez R., Gonzalez-Lamuno D. and Sanchez-Barcelo E. J. (2002) Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J. Pineal Res. 32: 90-94
63. Reppert S. M., Weaver D. and Ebisawa T. (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177-1185
64. Reppert S. M., Godson C., Mahle C. D., Weaver D. R., Slaugenhaupt S. A. and Gusella J. F. (1995). Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Me11b melatonin receptor. Proc. Natl. Acad. Sci. USA 92: 8734-8738
65. Vacas M. I., Sarmiento M. I. and Cardinali D. P. (1981) Melatonin increases cGMP and decreases cAMP levels in rat medial basal hypothalamus in vitro. Brain Res. 225: 207-211
66. Reppert S. M. (1997) Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J. Biol. Rhythms. 12: 528-531
67. Dubocovich M. L., Masana M. I. and Benloucif S. (1999) Molecular pharmacology and function of melatonin receptor subtypes. Adv. Exp. Med. Biol. 460: 181-190
68. Menendez-Pelaez A., Poeggeler B., Reiter R. J., Barlow-Walden L., Pablos M. I. and Tan D. X. (1993) Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 53: 373-382
69. Acuna-Castroviejo D., Pablos M. I., Menendez-Pelaez A. and Reiter R. J. (1993) Melatonin receptors in purified cell nuclei of liver. Res. Commun. Chem. Pathol. Pharmacol. 82: 253-256
70. Becker-André M., Wiesenberg I., Schaeren-Wiemers N., André E., Missbach M., Saurat J. H. et al. (1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269: 28531-28534
71. Wiesenberg I., Missbach M., Kahlen J. P., Schräder M. and Carlberg C. (1995). Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP52608 as a synthetic ligand. Nucleic Acids Res. 23: 327-333
72. Garcia-Maurino S., Pozo D., Calvo J. R. and Guerrero J. M. (2000) Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphatic and monocytic cell lines. J. Pineal Res. 29: 129-137
73. Carlberg C. (2000) Gene regulation by melatonin. Ann. N. Y. Acad. Sci. 917: 387-396
74. Benitez-King G., Huerto-Delgadillo L. and Antón-Tay F. (1993) Binding of 3H-melatonin to calmodulin. Life Sci. 53: 201-207
75. Acuña-Castroviejo D., Martin M., Macias M., Escames G., Leon J., Khaldy H. et al. (2001) Melatonin, mitochondria and cellular bioenergetics. J. Pineal Res. 30: 65-74
76. Tan D. X., Chen L. D., Poeggeler B., Manchester L. C. and Reiter R. J. (1993) Melatonin: a potent, endogenous, hydroxyl radical scavenger. Endocrine J. 1: 57-60
77. Reiter R. J., Acuna-Castroviejo D., Tan D. X. and Burkhardt S. (2001) Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann. N. Y. Acad. Sci. 939: 200-215
78. Pablos M. I., Agapito M. T., Gutierrez R., Recio J. M. and Menendez-Pelaez A. (1995) Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J. Pineal Res. 19: 111-115
79. Antolin I., Rodriguez C., Sainz R. M., Mayo J. C., Uria H., Kotler M. et al. (1996) Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidative enzymes. FASEB J. 10: 882-890
80. Mayo J. C., Sainz R. M., Martin V., Herrera I., Antolin I. and Rodriguez C. (2003) Melatonin regulation of antioxidant enzyme gene expression. Cell. Mol. Life. Sci. 59: 1706-1713
81. Pozo D., Reiter R. J., Calvo J. R. and Guerrero J. M. (1994) Physiological concentrations of melatonin inhibit nitric oxide synthase in the cerebellum. Life Sci. 55: PL455-PL460
82. Pozo D., Reiter R. J., Calvo J. R. and Guerrero J. M. (1997) Inhibition of cerehellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell. Biochem. 65: 430-442
83. Reiter R. J., Tan D. X., Osuna C. and Gitto E. (2000) Actions of melatonin in the reduction of oxidative stress. J. Biomed. Sci. 7: 444-458
84. Manev H., Uz T., Kharlamov A. and Joo J. Y. (1996) Increased brain damage after stroke or excitotoxic seizures in melatonindeficient rats. FASEB J. 10: 1546-1551
85. Cho S., Joh T. H., Bails H. H., Dibinis C. and Volpe B. T. (1997) Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats. Brain Res. 755: 335-338
86. Sewerynek E., Reiter R. J., Melchiorri D., Ortiz G. G. and Lewinski A. (1996) Oxidative damage in the livr induced by ischemia-reperfusion: protection by melatonin. Hepato-Gastroenterology 43: 898-905
87. Konturek P. C., Konturek S. J., Majka J., Zembala M. and Hahn E. G. (1997) Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosai microcirulatory effects. Eur. J. Pharmacol. 322: 73-77
88. Tan D. X., Manchester L. C., Reiter R. J., Qi W., Kim S. J. and El-Sokkary G. (1998) Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J. Pineal Res. 25: 184-191
89. Reiter R. J., Tan D. X., Manchester L. C. and Calvo J. R. (2002) Antioxidant capacity of melatonin. In: Handbook of Antioxidants, pp. 565-613, Cadenes E. and Packer L. (eds), Marcel Dekker, NY
90. Maestroni G. J. M., Covacci V. and Conti A. (1994) Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res. 54: 2429-2432
91. Cohen J. J. (1991) Programmed cell death in the immune system. Adv. Immunol. 50: 55-85
92. Cohen J. J. and Duke R. C. (1984) Glucocorticoid activation of a calcium dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132: 38-42
93. McConkey D. J. and Orrenius S. (1991) Cellular signaling in thymocyte apoptosis. In: Apoptosis: The Molecular Basis of Cell Death, pp. 227-246, Tomei L. D. and Cope F. O. (eds), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
94. Cohen J. J. (1992) Glucocorticoid-induced apoptosis in the thymus. Semin. Immunol. 4: 363-369
95. Maestroni G. J. M. and Conti A. (1993) Melatonin in relation to the immune system. In: Melatonin: Biosynthesis, Physiological Effects and Clinical Application, pp. 290-309, Hing-Sing Y. and Reiter R. J. (eds), CRC Press, Boca Raton, FL
96. Csaba C. and Barath P. (1975) Morphological changes of thymus and the thyroid gland after postnatal extirpation of the pineal body. Endocrinol. Exp. 9: 59-67
97. Maestroni G. J. M., Conti A. and Pierpaoli W. (1994) Role of the pineal gland in immunity II. Melatonin enhances the antibody response via an opiatergic mechanism. Clin. Exp. Immunol. 68: 384-391
98. Vaughan M. K. and Reiter R. J. (1971) Transient hypertrophy of the ventral prostate and coagulation glands and accelerated thymic involution following pinealectomy in the mouse. Texas Rep. Biol. Med. 29: 579-586
99. Jankovic B. D., Isakovic K. and Petrovic S. (1970) Effect of pinealectomy on immune reactions in the rat. Immunology 8: 1-5
100. Provinciali M., Di Stefano G., Bulian D., Tibaldi A. and Fabris N. (1996) Effect of melatonin and pineal grafting on thymocyte apoptosis in aging mice. Mech. Ageing Dev. 90: 1-19
101. Ashwelll J. D., Lu F. W. and Vacchio M. S. (2000) Glucocorticoids in T cell development and function. Ann. Rev. Immunol. 18: 309-345
102. Sainz R. M., Mayo J. C., Reiter R. J., Antolin I., Estehan M. M. and Rodriguez C. (2000) Melatonin regulates glucocorti-cold receptor: an answer to its antiapoptotic action in thymus. FASEB J. 13: 1547-1556
103. Tian Y. M., Li P. P., Jiang X. F., Zhang G. Y. and Dai Y. R. (2001) Rejuvenation of degenerative thymus by oral melatonin administration and the antagonistic action of melatonin against hydroxyl radical-induced apoptosis of cultured thymocytes in mice. J. Pineal Res. 31: 214-221
104. Wolfe J. T., Ross D. and Cohen G. M. (1994) A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett. 352: 58-62
105. Ramakrishnan N. and Catravas G. N. (1992) N-(2-mercaptoethyl)-1,3-propanediaminie (WR1065) protects thymocytes form programmed cell death. J. Immunol. 148: 1817-1821
106. McLaughlin K. A., Osborne B. A. and Boldsby R. A. (1996) The role of oxygen in thymocyte apoptosis. Eur. J. Immunol. 26: 1170-1174
107. Tome M. E. and Briehl M. M. (2001) Thymocyte selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis. Cell. Death Diff. 8: 953-961
108. Pozo D., Delgado M., Fernandez-Santos J. M., Calvo J. R., Gomariz R. P., Martin-Lacave I. et al. (1997) Expression of the Me11a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. FASEB J. 11: 466-473
109. Rafii-El-Idrissi M., Calvo J. R., Harmouch A., Garcia-Maurino S. and Guerrero J. M. (1998) Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat. J. Neuroimmunol. 86: 190-197
110. Yu Q., Miller S. C. and Osmond D. G. (2000) Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow. J. Pineal Res. 29: 86-93
111. Maestroni G. J. M., Hertens E., Galli P., Conti A. and Pedrinis E. (1996) Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleuking-4 and dynorphin. J. Pineal Res. 21: 131-139
112. Tan D. X., Manchester L., Reiter R. J., Qi W., Zhang M., Weintraub S. T. et al. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta 1472: 206-214
113. Conti A., Conconi S., Hertens E., Skwarlo-Sonta K., Markowska M. and Maestroni G. J. M. (2000) Evidence for melatonin synthesis in mouse and human bone marrow cells. J. Pineal Res. 28: 193-202
114. Nagler R. M., Eichen Y. and Nagler A. (2001) Redox metal chelation ameliorates radiation-induced bone marrow toxicity in a mouse model. Radiant Res. 156: 205-209
115. Lissoni P., Tancini G., Barni S., Paolorossi F., Rossini F., Maffe P. et al. (1996) The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia. Recenti. Prog. Med. 87: 582-585
116. Carbonari M., Cibati M., Cherchi M., Sbarigia D., Pesce A. M., Dell'Anna L. et al. (1994) Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 83: 1268-1277
117. Crompton N. E., Miralbell R., Rutz H. P., Ersoy F., Sanal O., Wellmann D. et al. (1999) Altered apoptotic profiles in irradiated patients with increased toxicity. Int. J. Radiat. Oncol. Biol. Phys. 45: 707-714
118. Reiter R. J., Tan D. X., Sainz R. M., Mayo J. C. and Lopez-Burillo S. (2002) Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm Pharmacol. 54: 1299-1321
119. Vijayalaxmi Meltz M. L., Reiter R. J., Herman T. S. and Krumar S. (1999) Melatonin and protection from whole-body irradiation: survival studies in mice. Mutant. Res. 425: 21-27
120. Vijayalaxmi Reiter R. J. and Meltz M. L. (1995) Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutant. Res. 346: 23-31
121. Burek M. J. and Oppenheim R. W. (1996) Programmed cell death in the developing nervous system. Brain Pathol. 6: 427-46
122. Mattson M. P. (2000) Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell. Biol. 1: 120-129
123. Cagnoli C. M., Atabay C., Kharlamova E. and Manev H. (1995) Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18: 222-226
124. Poeggeler B., Reiter R. J., Tan D. X., Chen L. D. and Manchester L. C. (1993) Melatonin, hydroxyl radical-mediated oxidative damage and aging: a hypothesis. J. Pineal Res. 14: 151-168
125. Uz T., Giusti P., Franceschini D., Kharlamov A. and Manev H. (1996) Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 73: 631-636
126. Chen S. T. and Chuang J. I. (1999) The antioxidant melatonin reduces cortical neuronal death after intrastriatal injection of kainate in the rat. Exp. Brain Res. 124: 241-247
127. Nowak J. Z., Kazula A. and Golembiowska K. (1992) Melatonin increases serotonin N-acetyltransferase activity and decreases dopamine synthesis in light-exposed chick retina: in vivo evidence supporting melatonin-dopamine interaction in retina. J. Neurochem. 59: 1499-505
128. Blazynski C. and Dubocovich M. (1991) Localization of 2-[I125]-iodomelatonin binding sites in the mammalian retina. J. Neurochem. 57: 685-689
129. Nash M. S. and Osborne N. N. (1995) Pertussis toxin-sensitive melatonin receptors negatively coupled to adenylate cyclase associated with cultured human and rat retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 36: 95-102
130. Osborne N. N., Cazevieille C., Pergande G. and Wood J. P. M. (1997) Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirine. Invest. Ophthalmol. Vis. Sci. 38: 1390-1400
131. Osborne N. N., Nash M. S. and Wood J. P. (1998) Melatonin counteracts ischemia-induced apoptosis in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 39: 2374-2383
132. Dubocovich M. L. (1998) Luzindole (N-0774): a novel melatonin receptor antagonist. J. Pharmacol. Exp. Ther. 246: 902-910
133. Liang F. Q., Aleman T. S., Zaixin Y., Cideciyan A. V., Jacobson S. G. and Bennett J. (2001) Melatonin delays photoreceptor degeneration in the rds/rds mouse. Neuroreport 12: 1011-1014
134. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J. and Cotman C. V. (1993) Apoptosis is induced by β-amyloid in culture central nervous system neurons. Proc. Natl. Acad. Sci. USA 90: 7951-7955
135. Paradis E., Doullard H., Koutroumanis M., Goodyer C. and Leblanc A. (1996) Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci. 16: 7533-7539
136. Behl C., Davis J. B., Lesley R. and Schubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827
137. Morel R., Doussiere J. and Vignais P. V. (1991) The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur. J. Biochem 201: 523-546
138. Pappolla M. A., Simovich M. J., Bryant-Thomas T., Chyan Y.-J., Poeggeler B., Dubocovich M. et al. (2002) The neuroprotective activities of melatonin against the Alzheimer β-protein are not mediated by melatonin membrane receptors. J. Pineal Res. 32: 135-142
139. Pappolla M. A., Bozner P., Soto C., Shao H., Robakis N., Zagorski M. et al. (1998). Inhibition of Alzheimer β-fibrillo-genesis by melatonin. J. Biol. Chem. 273: 7185-7189
140. Shen Y. X., Xu X. Y., Wei W., Wang X. L., Wang H. and Sun X. (2002) Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35. J. Pineal Res. 32: 163-167
141. Tompkins M. M., Basgall E. J., Zamrini E. and Hill W. D. (1997) Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150: 119-131
142. Hartmann A., Hunot S., Michel P. P., Muriel M. P., Vyas S., Faucheux B. A. et al. (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA 97: 2875-2880
143. Acuña-Castroviejo D., Coto-Montes A., Monti G., Ortiz G. G. and Reiter R. J. (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci. 60: 23-29
144. Ortiz G. G., Crespo-Lopez M. E., Moran-Moguel C., Garcia J. J., Reiter R. J. and Acuña-Castroviejo D. (2001) Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo. Neuroendocrinol Lett. 22: 101-108
145. Antolin I., Mayo J. C., Sainz R. M., del Brio M. A., Herrera F., Martin V. et al. (2002) Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res. 943: 163-173
146. Walkinshaw G. and Waters C. M. (1994) Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63: 975-987
147. Andersen J. K. (2001) Does neuronal loss in Parkinson's disease involve programmed cell death? Bioessays 23: 640-646
148. Mayo J. C., Sainz R. M., Uria H., Antolin I., Esteban M. M. and Rodriguez C. (1998) Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J. Pineal Res. 24: 179-192
149. Mayo J. C., Sainz R. M., Antolin I. and Rodriguez C. (1999) Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage. Brain Res. 818: 221-227
150. Yoo Y. M., Yim S. V., Kim S. S., Jang H. Y., Lea H. Z., Hwang G. C. et al. (2002) Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-beta immortalized pineal cells. J. Pineal Res. 33: 146-150
151. Schulz J. B., Weller M. and Klockgether T. (1996) Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis. ICE-lide protease activity and reactive oxygen species. J. Neurosci. 16: 4696-4706
152. Skaper S. D., Floreani M., Negro A., Facci L. and Giusti P. (1998) Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J. Neurochem. 70: 1859-1868
153. Soltoff S. P., Rabin S. L., Cantley L. C. and Kaplan D. R. (1992) Nerve growth factor promotes the activation of phosphatidyl-inositol 3-kinase and its association with the trk tyrosine kinase. J. Biol. Chem. 267: 17472-17477
154. Shimoke K., Kubo T., Numakawa T., Abiru Y., Enokido Y., Takei N. et al. (1997) Involvements of phophatildylinositol 3-kinase in prevention of low K+ -induced apoptosis of cerebellar granule neurons. Dev. Brain Res. 101: 197-206
155. Iacovitti L., Stull N. D. and Mishizen A. (1999) Neurotransmitters, KCl and antioxidants rescue striatal neurons from apoptotic cell death in culture. Brain Res. 816: 276-285
156. Lizard G., Miguet C., Bessede G., Monier S., Gueldry S., Neel D. et al. (2000) Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occurring during 7-ketocholesterol-induced apoptosis. Free Rad. Biol. Med. 28: 743-753
157. Kolsch H., Ludwig M., Lutjohann D. and Rao M. L. (2001) Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β. J. Neural. Transm. 108: 475-488
158. Harms C., Lautenschlager M., Bergk A., Freyer D., Weih M., Dirnagl U. et al. (2000) Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures. FASEB J. 14: 1814-1824
159. Deigner H. P., Haberkorn U. and Knscherf R. (2000) Apoptosis modulator in the therapy of neurodegenerative diseases. Expert Opin. Investing Drugs 9: 747-764
160. Brewer G. J. (2000) Neuronal plasticity and stressor toxicity during aging. Exp. Gerontol. 35: 1165-1183
161. Tricoire H., Locatelli A., Chemineau P. and Malpaux B. (2002) Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 143: 84-90
162. Tan D. X., Manchester L. C., Reiter R. J., Qi W., Hanes M. A. and Farley N. J. (1999) High physiological levels of melatonin in bile of mammals. Life Sci. 65: 2523-2529
163. Reiter R. J. and Tan D. X. (2002) Role of CSF in the transport of melatonin. J. Pineal Res. 33: 61
164. Reiter R. J. (1992) The aging pineal gland and its physiological consequences. Bioessays 14: 169-175
165. Jahnke G., Marr M., Myers C., Wilson R., Travlos G. and Price G. (1999) Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant SpragueDawley rats. Toxicol. Res. 50: 271-279
166. Seabra M., Bignotto M., Pinto L. R. Jr and Tufik S. (2000) Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J. Pineal Res. 29: 193-200
167. Jan J. E., Hamilton D., Seward N., Fast D. K., Freeman R. D. and Laudon M. (2001) Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J. Pineal Res. 29: 34-39
168. Poeggeler B., Thuermann S., Dose A., Schoenke M., Burkhardt S. and Hardeland R. (2002) Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs. J. Pineal Res. 33: 20-30
169. Aoshima H., Kadoya K., Taniguchi H., Satoh T. and Hatanaka H. (1999) Generation of free radicals during the death of Saccharomyces cerevisiae caused by lipid hydroperoxide. Biosci. Biotechnol. Biochem. 63: 1025-1031
170. Shikh A. Y., Xu J., Wu Y., He L. and Hsu C. Y. (1997) Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death. Neurosci. Lett. 229: 193-197
171. Ryoo Y. W., Suh S. I., Mun K. C., Kim B. C. and Lee K. S. (2001) The effects of melatonin on ultraviolet-B irradiated cultured dermal fibroblasts. J. Dermatol. Sci. 27: 162-169
172. Kim B. C., Shon B. S., Ryoo Y. W., Kim S. P. and Lee K. S. (2001) Melatonin reduces X-ray irradiation-induced oxidative damage in cultured human skin fibroblast. J. Dermatol. Sci. 26: 194-200
173. Girardi G., Torres M. A. and Elias M. M. (1989). The implication of renal glutathione levels in mercuric chloride nephrotoxicity. Toxicology 58: 187-195
174. Nava M., Romero F., Quiroz Y., Parra G., Bonet L. and Rodriguez-Iturbe B. (2000) Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats. Am. J. Physiol. Renal Physiol. 279: F910-F918
175. Meki A. R., Abdel-Ghaffar S. K. and El-Gibaly I. (2001). Aflatoxin B1 induces apoptosis in rat liver: protective effect of melatonin. Neuroendocrinol. Lett. 22: 417-426
176. Liu X., Chen Z., Chua C. C., Ma Y. S., Youngberg G. A., Hamdy R. et al. (2002) Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am. J. Physiol. Heart Circ. Physiol. 283: H254-H263
177. Bartsch C. and Bartsch H. (1999) Melatonin in cancer patients and in tumor-bearing animals. Adv. Exp. Med. Biol. 467: 247-264
178. Blask D. E., Hill S. M., Orstead K. M. and Massa J. S. (1986) Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzatracene (DMBA)-induced mammary tumorigenesis. J. Neural Transm. 67: 125-138
179. Blask D. E., Pelletier D. B., Hill S. M., Lemus-Wilson A., Grosso D. S., Wilson S. T. et al. (1991) Pineal melatonin inhibition of tumor promotion in N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J. Cancer Res. Clin. Oncol. 117: 526-532
180. Eck K. M., Yuan L., Duffy L., Ram P. T., Ayettey S., Chen I. et al. (1998) A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. British J. Cancer 77: 2129-2137
181. Lacroix A. and Lippman M. E. (1980) Binding of retinoids to human breast cancer cell lines and their effects on cell growth. J. Clin. Invest. 65: 586-591
182. Eck-Enriquez K., Kiefer T. L., Spriggs L. and Hill S. M. (2000) Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 61: 229-239
183. Lefebvre P., Baub M. P., Tahayato A., Rochette-Egly C. and Formstcher P. (1995) Protein phosphatases I and 2A regulate the transcriptional and DNA binding acitivities of retinoic acid receptors. J. Biol. Chem. 270: 10806-10816
184. Nowfar S., Teplitzky S. R., Melancon K., Keifer T. L., Cheng Q., Dwived P. D. et al. (2002) Tumor prevention by 9-cisretinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Breast Cancer Res. Treat. 72: 33-43
185. Cos S., Mediavilla M. D., Fernandez R., Gonzalez-Lamuno D. and Sanchez-Barcelo E. J. (2002) Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J. Pineal Res. 32: 90-96
186. Karasek M., Winczyk K., Kunert-Radk J., Wiesenberg I. and Pawlikowski M. (1998) Antiproliferative effects of melatonin and CGP52608 on the murine colon 38 adenocarcinoma in vitro and in vivo. Neuroendocrinol. Lett. 19: 71-78
187. Melen-Mucha G., Winczyk K. and Pawlikowski M. (1998) Somatostatin analogue oxtreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer. Anticancer Res. 18: 3615-3620
188. Winczyk K., Pawlikowski M. and Karasek M. (2001) Melatonin and RZR/ROR receptor ligand CGP52608 induce apoptosis in the murine colonic cancer. J. Pineal Res. 31: 179-182
189. Winczyk K., Pawlikowski M., Lawnicka H., Kunert-Radek J., Spadoni G., Tarzia G. et al. (2002) Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2yl) methyl] propanamide on murine Colon 38 cancer growth in vitro and in vivo. Neuroendocrinol. Lett. 1: 50-54
190. El-Missiry M. A. and Abd El-Aziz A. F. (2000) Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells. Cancer Lett. 151: 119-125
191. Anisimov V. N., Popovich I. G., Shtylik A. V., Zabezhinski M. A., Ben-Huh H., Gurevich P. et al. (2000) Melatonin and colon carcinogenesis III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Exp. Toxicol. Pathol. 52: 71-76
192. Wolfler A., Caluba H. C., Abuja P. M., Dohr G., Schauenstein K. and Liebmann P. M. (2001) Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett. 502: 127-131
193. Williams M. S. and Henkart P. A. (1996) Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157: 2395-2402
194. Delneste Y., Jeannin P., Sebille E., Aubry J. P. and Bonnefoy J. Y. (1996) Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression. Eur. J. Immunol. 26: 2981-2988
195. Gunawardena K., Murray D. K. and Meikle A. W. (2000) Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate 44: 287-295
196. Neuzil J., Weber T., Terman A., Weber C. and Brunk U. T. (2001) Vitamin E analogues as inducers of apoptosis: implications for their potential antineoplastic role. Redox Rep. 6: 143-151
197. Bhat K. P. and Pezzuto J. M. (2002) Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 957: 210-229
198. Muller K., Carpenter K. L., Challis I. R., Skepper J. N. and Arends M. J. (2002) Carotenoids induce apoptosis in the T-lymphoblast cell line Jurkat E6.1. Free Radic. Res. 36: 791-802
199. Hattori A., Migitaka H., Ligo M., Itoh M., Yamamoto K., Ohtani-Kaneko R. et al. (1995) Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int. 35: 627-634